about
Cancer-related hypercalcemiaParathyroid cancerMolecular Insight into Substrate Recognition and Catalysis of Baeyer–Villiger Monooxygenase MtmOIV, the Key Frame-Modifying Enzyme in the Biosynthesis of Anticancer Agent MithramycinGene environment interaction in periphery and brain converge to modulate behavioral outcomes: Insights from the SP1 transient early in life interference rat modelPrevalence of hypercalcemia of malignancy among pediatric cancer patients in the UK Clinical Practice Research Datalink database.Parathyroid cancer.Quality and Outcomes of Treatment of Hypercalcemia of Malignancy.Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents.Prevalence of hypercalcemia among cancer patients in the United StatesDenosumab: a new agent in the management of hypercalcemia of malignancy.Hypercalcaemia and hypocalcaemia: finding the balance.Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients.Serum calcium, albumin and tumor stage in cutaneous malignant melanomaA platform for designing hyperpolarized magnetic resonance chemical probes.Animal Models of Cancer-Associated Hypercalcemia.Denosumab Therapy for Refractory Hypercalcemia Secondary to Squamous Cell Carcinoma of Skin in Epidermolysis Bullosa.Malignancy-Related Hypercalcemia in Advanced Solid Tumors: Survival Outcomes.L’hypercalcémie reliée au cancer.Hypercalcemia of malignancy treated with cinacalcet.Double Trouble - Severe Hypernatremia Secondary to Central Diabetes Insipidus Complicated by Hypercalcemic Nephrogenic Diabetes Insipidus: A Case Report
P2860
Q24629382-ECF94B15-F1C6-4EAE-A87F-09CC2FF1861CQ26796612-2185D208-E8F3-4170-B811-16298934A645Q27679838-DAC14695-1F00-411C-98D0-6088F9F72D65Q28066795-6A23DFC4-0BBE-43E3-B340-E955A8EDAB40Q33821138-449F6574-9A43-4FF0-B4A2-5F115144B1A0Q34686824-D5591CFB-3448-4A98-A055-79D9697F40A2Q36338328-446562D7-2551-460F-9447-5B13C87BAC10Q36412591-B33358EB-F742-4A06-89FA-D1A031BA7896Q36788277-33743A72-02EC-4F13-B3ED-9DF429014034Q36983904-DA824064-18DC-4056-923B-B665A346360DQ37158465-6DEB481A-DE4A-4B52-ACC9-771A64EB7B41Q37736066-74BE2AD3-0149-449B-80FD-6B106DF44159Q38648494-15718309-1D6C-42B3-B83D-87B847A8C8CBQ38852740-C35CE41C-9CAA-41F4-9DF3-889E220F102FQ42643016-3BF995B8-5C52-4010-B052-2876492813F7Q43378586-EAC11EE0-9FCB-4940-B6AD-628E518116A7Q43973225-DB2EB3AE-13F3-4C38-93B7-F79B51B1015BQ47095666-3E7FD1E2-AC42-4827-9216-D23EC1ADBBC7Q47117647-5E60E606-D4EA-4A41-A16B-365348376DCCQ49207905-C95C0FBF-A753-4FDD-A3C4-2F1152518786Q58766802-90A763AD-8991-4836-8189-7F8EF50D5A23
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cancer-induced hypercalcemia.
@ast
Cancer-induced hypercalcemia.
@en
Cancer-induced hypercalcemia.
@nl
type
label
Cancer-induced hypercalcemia.
@ast
Cancer-induced hypercalcemia.
@en
Cancer-induced hypercalcemia.
@nl
prefLabel
Cancer-induced hypercalcemia.
@ast
Cancer-induced hypercalcemia.
@en
Cancer-induced hypercalcemia.
@nl
P2093
P1433
P1476
Cancer-induced hypercalcemia.
@en
P2093
Antonella Brunello
Franco Lumachi
Umberto Basso
P304
P407
P577
2009-05-01T00:00:00Z